サンプル依頼リスト カート
  • English
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1694825

初代細胞の世界市場レポート 2025年

Primary Cells Global Market Report 2025

出版日
ページ情報
英文 200 Pages
納期
2～10営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.08円
初代細胞の世界市場レポート 2025年
出版日: 2025年03月04日
発行: The Business Research Company
ページ情報: 英文 200 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

初代細胞の市場規模は、今後数年で急成長が見込まれます。2029年にはCAGR10.1％で24億6,000万米ドルに成長します。予測期間の成長は、個別化医療への需要の増加、幹細胞研究への注目の高まり、投資の増加、細胞ベースアッセイの採用増加などに起因しています。予測期間中の主な動向としては、ヒト初代細胞の需要、研究ツールや技術の進歩、細胞ベースの治療法の採用などが挙げられます。

がん研究に対する政府助成金の増加は、今後の初代細胞市場の成長を促進すると予想されます。助成金とは、プロジェクト、イニシアチブ、組織、または個人に対して、その開発、運営、または特定の目標の達成を可能にするために提供される財政的支援を指します。初代細胞研究では、研究プロジェクト、人的支援、設備・インフラ、研修・教育、規制遵守、技術開発などを支援するために政府資金が使用されています。例えば、2022年5月、米国を拠点とする大規模な米国がん研究機関である米国がん研究所（AICR）は、2023年に490億米ドルの資金提供を要請しており、これは前年の464億米ドルに比べて41億米ドルの増加です。したがって、がん研究に対する政府助成金の増加は、初代細胞市場の成長を促進すると予想されます。

初代細胞市場の主要企業は、研究や治療開発の進展を促進するため、細胞培養や幹細胞製品を含む細胞製品のイノベーションに注力しています。例えば、無血清培地は、ウシ胎児血清（FBS）のような動物由来の血清を除いた細胞や組織培養用の増殖培地の一種です。2024年7月、バイオテクノロジーとライフサイエンスソリューションを専門とするインドのBioserve Biotechnologies（India）Private Ltd.は、REPROCELLの先進的幹細胞製品をインド市場に導入しました。これらの新製品は、科学研究と医薬品開発の進歩を促進し、同地域における再生医療と治療法発見の成長に貢献することを目的としています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、コロナ、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

  • 世界の初代細胞市場のPESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
  • 最終用途産業の分析
  • 世界の初代細胞市場：成長率分析
  • 世界の初代細胞市場の実績：規模と成長、2019～2024年
  • 世界の初代細胞市場の予測：規模と成長、2024～2029年、2034年
  • 世界の初代細胞総アドレス可能市場（TAM）

第6章 市場セグメンテーション

  • 世界の初代細胞市場：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
  • 造血細胞
  • 皮膚糸状菌
  • 消化管細胞
  • 肝細胞
  • 肺細胞
  • 腎細胞
  • 心臓細胞
  • 筋骨格細胞
  • その他
  • 世界の初代細胞市場：起源別、実績と予測、2019～2024年、2024～2029年、2034年
  • ヒト初代細胞
  • 動物由来初代細胞
  • 世界の初代細胞市場：エンドユーザー別、実績と予測、2019～2024年、2024～2029年、2034年
  • 医薬品
  • バイオテクノロジー企業
  • 契約研究機関（CRO）
  • 学術研究機関
  • その他
  • 世界の初代細胞市場：造血細胞のサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
  • 骨髄由来細胞
  • 末梢血由来細胞
  • 世界の初代細胞市場：皮膚糸状菌のサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
  • ケラチノサイト
  • 線維芽細胞
  • 世界の初代細胞市場：消化管細胞のサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
  • 腸管上皮細胞
  • 杯細胞
  • パネート細胞
  • 世界の初代細胞市場：肝細胞のサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
  • 肝実質細胞
  • 肝星細胞
  • 世界の初代細胞市場：肺細胞のサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
  • 肺胞上皮細胞
  • 気管支上皮細胞
  • 世界の初代細胞市場：腎細胞のサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
  • 近位尿細管細胞
  • 糸球体細胞
  • 世界の初代細胞市場：心臓細胞のサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
  • 心筋細胞
  • 心臓線維芽細胞
  • 世界の初代細胞市場：筋骨格細胞のサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
  • 筋芽細胞
  • 軟骨細胞
  • 世界の初代細胞市場：その他のサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
  • 内皮細胞
  • 脂肪細胞

第7章 地域別・国別分析

  • 世界の初代細胞市場：地域別、実績と予測、2019～2024年、2024～2029年、2034年
  • 世界の初代細胞市場：国別、実績と予測、2019～2024年、2024～2029年、2034年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • 初代細胞市場：競合情勢
  • 初代細胞市場：企業プロファイル
    • Thermo Fisher Scientific Inc Overview, Products and Services, Strategy and Financial Analysis
    • Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
    • BD Biosciences Overview, Products and Services, Strategy and Financial Analysis
    • Corning Incorporated Overview, Products and Services, Strategy and Financial Analysis
    • Cytiva Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

  • Lonza Group Ltd
  • Charles River Laboratories Inc.
  • STEMCELL Technologies Inc
  • American Type Culture Collection
  • Cell Signaling Technology
  • BioIVT
  • InvivoGen
  • HemaCare Corporation
  • Creative Bioarray Inc.
  • PromoCell GmbH
  • CellGenix
  • AllCells LLC
  • Axol Bioscience Ltd
  • PBS Biotech Inc
  • AnaBios Corporation

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

  • 初代細胞市場2029：新たな機会を提供する国
  • 初代細胞市場2029：新たな機会を提供するセグメント
  • 初代細胞市場2029：成長戦略
    • 市場動向に基づく戦略
    • 競合の戦略

第36章 付録

目次
Product Code: r28802

Primary cells refer to cells extracted directly from the living tissues of animals or people and then treated to prepare them for use in suitable cell treatments. These cells are employed in various applications, including 3D cell cultivation, virology, cancer research, stem cell treatment, and tissue restoration.

The main types of primary cells are hematopoietic cells, dermatophytes, gastrointestinal cells, hepatocytes, lung cells, renal cells, heart cells, musculoskeletal cells, and others. Hematopoietic cells are a type of stem cell that gives rise to the various blood cell types in the body. Its origins are human primary cells and animal primary cells, and its end users are pharmaceuticals, biotechnology companies, contract research organizations (CROs), academic and research institutes, and others.

The main types of primary cells are hematopoietic cells, dermatophytes, gastrointestinal cells, hepatocytes, lung cells, renal cells, heart cells, musculoskeletal cells, and others. Hematopoietic cells are a type of stem cell that gives rise to the various blood cell types in the body. Its origins are human primary cells and animal primary cells, and its end users are pharmaceuticals, biotechnology companies, contract research organizations (CROs), academic and research institutes, and others.

The primary cells market size has grown rapidly in recent years. It will grow from $1.49 billion in 2024 to $1.67 billion in 2025 at a compound annual growth rate (CAGR) of 12.0%. The growth in the historic period can be attributed to rising prevalence of cancer, increasing investments in regenerative medicine research, growing demand for monoclonal antibodies, advantages of primary human cells over cell lines, increasing prevalence of chronic diseases.

The primary cells market size is expected to see rapid growth in the next few years. It will grow to $2.46 billion in 2029 at a compound annual growth rate (CAGR) of 10.1%. The growth in the forecast period can be attributed to increasing demand for personalized medicine, growing focus on stem cell research, rising investments, increasing adoption of cell-based assays. Major trends in the forecast period include demand for human primary cells, advancements in research tools and technologies, adoption of cell-based therapies.

The rising government funding for cancer research is expected to propel the growth of the primary cells market going forward. Funding refers to the financial support provided to a project, initiative, organization, or individual to enable its development, operation, or achievement of specific goals. Government funding is used in primary cells to support research projects, personnel support, equipment and infrastructure, training and education, regulatory compliance, and technology development. For instance, in May 2022, the American Institute for Cancer Research (AICR), a US-based large American cancer research organization, requested $49 billion funding in 2023, which is an increase of $4.1 billion compared to the previous year's $46.4 billion. Therefore, rising government funding for cancer research is expected to propel the growth of the primary cell market.

Leading companies in the primary cell market are focusing on innovations in cell products, including cell culture and stem cell products, to drive progress in research and therapeutic development. Serum-free medium, for example, is a type of growth medium for cell or tissue cultures that excludes animal-derived serums, such as fetal bovine serum (FBS). In July 2024, Bioserve Biotechnologies (India) Private Ltd., an Indian company specializing in biotechnology and life sciences solutions, introduced advanced stem cell products from REPROCELL to the Indian market. These new products aim to foster advancements in scientific research and drug development, contributing to growth in regenerative medicine and therapeutic discovery in the region.

In April 2023, AnaBios Corporation, a US-based biotechnology company, acquired Cell Systems for an undisclosed amount. This acquisition was aimed at expanding AnaBios' unique human tissue and cell portfolio, providing enhanced translational tools and reagents to academic, pharmaceutical, and biotech researchers, and optimizing research programs through enhanced human insights. Cell Systems is a US-based biotechnology company that specializes in providing human primary cells and cell culture media.

Major companies operating in the primary cells market are Thermo Fisher Scientific Inc, Merck KGaA, BD Biosciences, Corning Incorporated, Cytiva, Lonza Group Ltd, Charles River Laboratories Inc., STEMCELL Technologies Inc, American Type Culture Collection, Cell Signaling Technology, BioIVT, InvivoGen, HemaCare Corporation, Creative Bioarray Inc., PromoCell GmbH, CellGenix, AllCells LLC, Axol Bioscience Ltd, PBS Biotech Inc, AnaBios Corporation, ReachBio Research Labs, PELOBIOTECH GmbH, Cell Biologics Inc., ZenBio Inc., StemBioSys Inc

North America was the largest region in the primary cells market in 2024. The regions covered in the primary cells market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the primary cells market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The primary cells market consists of revenues earned by entities by providing services such as cell isolation services, primary cell culture services, cell characterization, and authentication. The market value includes the value of related goods sold by the service provider or included within the service offering. The primary cell market also includes sales of cell culture media and reagents, cell culture plates and flasks, cell isolation kits, and transfection reagents. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Primary Cells Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on primary cells market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for primary cells ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The primary cells market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Hematopoietic Cells; Dermatophytes; Gastrointestinal Cells; Hepatocytes; Lung Cells; Renal Cells; Heart Cells; Musculoskeletal Cells; Other Primary Cells
  • 2) By Origin: Human Primary Cells; Animal Primary Cells
  • 3) By End User: Pharmaceuticals; Biotechnology Companies; Contract Research Organizations (CRO); Academic And Research Institutes; Other End Users
  • Subsegments:
  • 1) By Hematopoietic Cells: Bone Marrow-Derived Cells; Peripheral Blood-Derived Cells
  • 2) By Dermatophytes: Keratinocytes; Fibroblasts
  • 3) By Gastrointestinal Cells: Enterocytes; Goblet Cells; Paneth Cells
  • 4) By Hepatocytes: Liver Parenchymal Cells; Hepatic Stellate Cells
  • 5) By Lung Cells: Alveolar Epithelial Cells; Bronchial Epithelial Cells
  • 6) By Renal Cells: Proximal Tubular Cells; Glomerular Cells
  • 7) By Heart Cells: Cardiomyocytes; Cardiac Fibroblasts
  • 8) By Musculoskeletal Cells: Myoblasts; Chondrocytes
  • 9) By Other Primary Cells: Endothelial Cells; Adipocytes
  • Companies Mentioned: Thermo Fisher Scientific Inc; Merck KGaA; BD Biosciences; Corning Incorporated; Cytiva
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Primary Cells Market Characteristics

3. Primary Cells Market Trends And Strategies

4. Primary Cells Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Primary Cells Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Primary Cells PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Primary Cells Market Growth Rate Analysis
  • 5.4. Global Primary Cells Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Primary Cells Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Primary Cells Total Addressable Market (TAM)

6. Primary Cells Market Segmentation

  • 6.1. Global Primary Cells Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hematopoietic Cells
  • Dermatophytes
  • Gastrointestinal Cells
  • Hepatocytes
  • Lung Cells
  • Renal Cells
  • Heart Cells
  • Musculoskeletal Cells
  • Other Primary Cells
  • 6.2. Global Primary Cells Market, Segmentation By Origin, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Human Primary Cells
  • Animal Primary Cells
  • 6.3. Global Primary Cells Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Pharmaceuticals
  • Biotechnology Companies
  • Contract Research Organizations (CRO)
  • Academic And Research Institutes
  • Other End Users
  • 6.4. Global Primary Cells Market, Sub-Segmentation Of Hematopoietic Cells, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Bone Marrow-Derived Cells
  • Peripheral Blood-Derived Cells
  • 6.5. Global Primary Cells Market, Sub-Segmentation Of Dermatophytes, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Keratinocytes
  • Fibroblasts
  • 6.6. Global Primary Cells Market, Sub-Segmentation Of Gastrointestinal Cells, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Enterocytes
  • Goblet Cells
  • Paneth Cells
  • 6.7. Global Primary Cells Market, Sub-Segmentation Of Hepatocytes, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Liver Parenchymal Cells
  • Hepatic Stellate Cells
  • 6.8. Global Primary Cells Market, Sub-Segmentation Of Lung Cells, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Alveolar Epithelial Cells
  • Bronchial Epithelial Cells
  • 6.9. Global Primary Cells Market, Sub-Segmentation Of Renal Cells, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Proximal Tubular Cells
  • Glomerular Cells
  • 6.10. Global Primary Cells Market, Sub-Segmentation Of Heart Cells, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Cardiomyocytes
  • Cardiac Fibroblasts
  • 6.11. Global Primary Cells Market, Sub-Segmentation Of Musculoskeletal Cells, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Myoblasts
  • Chondrocytes
  • 6.12. Global Primary Cells Market, Sub-Segmentation Of Other Primary Cells, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Endothelial Cells
  • Adipocytes

7. Primary Cells Market Regional And Country Analysis

  • 7.1. Global Primary Cells Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Primary Cells Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Primary Cells Market

  • 8.1. Asia-Pacific Primary Cells Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Primary Cells Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Primary Cells Market, Segmentation By Origin, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Primary Cells Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Primary Cells Market

  • 9.1. China Primary Cells Market Overview
  • 9.2. China Primary Cells Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Primary Cells Market, Segmentation By Origin, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Primary Cells Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Primary Cells Market

  • 10.1. India Primary Cells Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Primary Cells Market, Segmentation By Origin, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Primary Cells Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Primary Cells Market

  • 11.1. Japan Primary Cells Market Overview
  • 11.2. Japan Primary Cells Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Primary Cells Market, Segmentation By Origin, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Primary Cells Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Primary Cells Market

  • 12.1. Australia Primary Cells Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Primary Cells Market, Segmentation By Origin, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Primary Cells Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Primary Cells Market

  • 13.1. Indonesia Primary Cells Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Primary Cells Market, Segmentation By Origin, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Primary Cells Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Primary Cells Market

  • 14.1. South Korea Primary Cells Market Overview
  • 14.2. South Korea Primary Cells Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Primary Cells Market, Segmentation By Origin, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Primary Cells Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Primary Cells Market

  • 15.1. Western Europe Primary Cells Market Overview
  • 15.2. Western Europe Primary Cells Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Primary Cells Market, Segmentation By Origin, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Primary Cells Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Primary Cells Market

  • 16.1. UK Primary Cells Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Primary Cells Market, Segmentation By Origin, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Primary Cells Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Primary Cells Market

  • 17.1. Germany Primary Cells Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Primary Cells Market, Segmentation By Origin, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Primary Cells Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Primary Cells Market

  • 18.1. France Primary Cells Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Primary Cells Market, Segmentation By Origin, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Primary Cells Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Primary Cells Market

  • 19.1. Italy Primary Cells Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Primary Cells Market, Segmentation By Origin, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Primary Cells Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Primary Cells Market

  • 20.1. Spain Primary Cells Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Primary Cells Market, Segmentation By Origin, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Primary Cells Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Primary Cells Market

  • 21.1. Eastern Europe Primary Cells Market Overview
  • 21.2. Eastern Europe Primary Cells Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Primary Cells Market, Segmentation By Origin, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Primary Cells Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Primary Cells Market

  • 22.1. Russia Primary Cells Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Primary Cells Market, Segmentation By Origin, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Primary Cells Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Primary Cells Market

  • 23.1. North America Primary Cells Market Overview
  • 23.2. North America Primary Cells Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Primary Cells Market, Segmentation By Origin, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Primary Cells Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Primary Cells Market

  • 24.1. USA Primary Cells Market Overview
  • 24.2. USA Primary Cells Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Primary Cells Market, Segmentation By Origin, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Primary Cells Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Primary Cells Market

  • 25.1. Canada Primary Cells Market Overview
  • 25.2. Canada Primary Cells Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Primary Cells Market, Segmentation By Origin, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Primary Cells Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Primary Cells Market

  • 26.1. South America Primary Cells Market Overview
  • 26.2. South America Primary Cells Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Primary Cells Market, Segmentation By Origin, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Primary Cells Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Primary Cells Market

  • 27.1. Brazil Primary Cells Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Primary Cells Market, Segmentation By Origin, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Primary Cells Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Primary Cells Market

  • 28.1. Middle East Primary Cells Market Overview
  • 28.2. Middle East Primary Cells Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Primary Cells Market, Segmentation By Origin, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Primary Cells Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Primary Cells Market

  • 29.1. Africa Primary Cells Market Overview
  • 29.2. Africa Primary Cells Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Primary Cells Market, Segmentation By Origin, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Primary Cells Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Primary Cells Market Competitive Landscape And Company Profiles

  • 30.1. Primary Cells Market Competitive Landscape
  • 30.2. Primary Cells Market Company Profiles
    • 30.2.1. Thermo Fisher Scientific Inc Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. BD Biosciences Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Corning Incorporated Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Cytiva Overview, Products and Services, Strategy and Financial Analysis

31. Primary Cells Market Other Major And Innovative Companies

  • 31.1. Lonza Group Ltd
  • 31.2. Charles River Laboratories Inc.
  • 31.3. STEMCELL Technologies Inc
  • 31.4. American Type Culture Collection
  • 31.5. Cell Signaling Technology
  • 31.6. BioIVT
  • 31.7. InvivoGen
  • 31.8. HemaCare Corporation
  • 31.9. Creative Bioarray Inc.
  • 31.10. PromoCell GmbH
  • 31.11. CellGenix
  • 31.12. AllCells LLC
  • 31.13. Axol Bioscience Ltd
  • 31.14. PBS Biotech Inc
  • 31.15. AnaBios Corporation

32. Global Primary Cells Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Primary Cells Market

34. Recent Developments In The Primary Cells Market

35. Primary Cells Market High Potential Countries, Segments and Strategies

  • 35.1 Primary Cells Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Primary Cells Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Primary Cells Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer